Johan Burisch

Country flagDenmark

Research Interests

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (21)

INTRODUCTION: Familial adenomatous polyposis (FAP) is an autosomal, dominantly inherited disorder that predisposes to colorectal cancer. An increased risk of cancer may affect mental health, but the magnitude of this effect remains unknown. We assessed the psychosocial functioning, including the educational level attained and risk of psychiatric comorbidity, of patients with FAP by comparing them with matched nonexposed individuals. METHODS: All Danish patients with FAP diagnosed before April 2021 were identified in the Danish Polyposis Register and paired with 4 matched nonexposed individuals. Educational history, psychiatric contacts or diagnoses ( International Classification of Disease, 10th Revision ), and treatment with antidepressants, anxiolytics, or antipsychotics were compared between patients with FAP and nonexposed individuals. RESULTS: The analysis included 445 patients with FAP and 1,538 nonexposed individuals. The highest educational level reached was significantly lower for patients with FAP ( P < 0.001). When comparing patients with FAP and nonexposed and adjusting for a cancer diagnosis, an increased risk was observed for a psychiatric contact (1.69, 95% confidence interval [CI] 1.25–2.29, P < 0.001), any psychiatric prescription (1.39, 95% CI 1.17–1.66, P < 0.001), a psychiatric diagnosis (1.64, 95% CI 1.19–2.26, P = 0.002), and experiencing any psychiatric event (hazard ratio 1.42, 95% CI 1.20–1.68, P < 0.001). An increased risk was specifically seen for mood (affective) disorders (1.76, 95% CI 1.09–2.83, P = 0.02) and behavioral and emotional disorders (2.01, 95% CI 1.10–3.69, P = 0.02) and the need for antidepressants (1.59, 95% CI 1.24–2.03, P < 0.001) and antipsychotics (1.85, 95% CI 1.26–2.70, P = 0.002). DISCUSSION: Compared with nonexposed individuals, patients with had significantly less education and an increased risk of developing mood and behavioral disorders, with an increased likelihood of needing antidepressants and antipsychotics.

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (18)

Bjorn Klinge

Karolinska Institutet

SWEDEN
View details

Thomas Greuter

-

SWITZERLAND
View details

Tim Raine

Cambridge University Hospitals NHS Foundation Trust

UNITED KINGDOM
View details

Tasanee Braithwaite

Honorary and Adjunct Senior Lecturer

-

UNITED KINGDOM
View details

Georgios Tsakos

University College London

UNITED KINGDOM
View details

Simon F. Thomsen

-

DENMARK
View details

Nikolaos Pandis

-

SWITZERLAND
View details

Hans-Christian Pommergaard

-

DENMARK
View details

Triana Lobaton Ortega

Ghent University Hospital

BELGIUM
View details

Rune Wilkens

Københavns Universitet

DENMARK
View details

Andreas Stavropoulos

-

SWEDEN
View details

Nora Vladimirova

-

DENMARK
View details

Casper Steenholdt

Professor, Chief Physician

University of Southern Denmark

DENMARK
View details

Kristina Bertl

-

AUSTRIA
View details

Jordan Axelrad

Assistant Professor

NYU Langone Health

UNITED STATES
View details

Christopher Ma

Assistant Professor

University of Calgary

CANADA
View details

Ole Haagen Nielsen

Københavns Universitet

DENMARK
View details

Thomas Scheike

Københavns Universitet

DENMARK
View details
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.